Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect(CSD) patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clearly diagnosed with CSD complicated with adenomyosis

Experiencing clinical features of abnormal uterine bleeding, prolonged menstrual flow (the duration of menstruation is more than 10 days).

The thickness of the remaining muscular layer of CSD was less than 3 mm.

Normal range of blood sugar and insulin

Disqualifiers

Indefinite diagnosis.

Malignant tumors.

With severe medical problems (severe liver disease, kidney disease, respiratory diseases, heart disease or uncontrolled diabetes, epilepsy, etc., dysfunction of important organs).

Pregnant.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Leuprorelin

    Drug

    Leuprorelin will be used to postpone period after vaginal repair.

Treatment groups

94 Participants
are divided into 2 treatment groups
Group A: Vaginal Repair with LeuprorelinExperimental treatment 1 intervention
Group B: Vaginal Repair without LeuprorelinNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

thickness of the remaining muscular layer (TRM) (mm)

The thickness of the remaining muscular layer is measured by magnetic resonance imaging (MRI)

Time frame
12 weeks after vaginal repair of CSD
2

Duration of menstruation (day)

Duration of menstruation (day)

Time frame
12 weeks after vaginal repair of CSD

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.